Sugammadex, neostigmine and postoperative pulmonary complications (the SNaPP Study) (ACTRN12623000394640)
SNaPP Study
This trial is No longer recruiting
Registration number ACTRN12623000394640
Program & service
This trial is being run with the Surgery service, and as part of the Anaesthesia & Perioperative Medicine program.
Trial phase
Phase 4
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Professor Paul Myles
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR